VF
CRXTW

Virtu Financial’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Virtu Financial’s Portfolio CRXTW Stock Details CRXTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,479
Closed -$2K – 2363
2022
Q1 		$2K Buy
+13,479
New +$2.44K ﹤0.01% 1431
2021
Q4 		– Sell
-16,527
Closed -$12K – 2405
2021
Q3 		$12K Buy
16,527
+5,450
+49% +$4.11K ﹤0.01% 1408
2021
Q2 		$8K Buy
+11,077
New +$6.95K ﹤0.01% 1431

Other funds holding CRXTW

LP
LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $2.1B AUM 70.99% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $12B AUM 34.44% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return